Secoisolariciresinol Diglucoside Regulates Adipose Tissue Metabolic Disorder in Obese Mice Induced by a Western Diet
Secoisolariciresinol diglucoside (SDG) is the main component of flax lignans. Current studies have reported a positive effect of SDG on obesity and metabolic diseases. SDG has strong blood fat- and blood sugar-lowering, anti-inflammatory, and antioxidant effects and prevents heart disease and other...
Main Authors: | Shan Dong, Wenliang Bai, Jiaping Chen, Li Zhang, Wanli Sheng, Ronghu Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2021-01-01
|
Series: | Journal of Food Quality |
Online Access: | http://dx.doi.org/10.1155/2021/5580772 |
Similar Items
-
Secoisolariciresinol diglucoside effects in diet-Induced hyperlipidemic rats
by: Woo, Gloria
Published: (2006) -
Flaxseed lignan secoisolariciresinol diglucoside improves insulin sensitivity through upregulation of GLUT4 expression in diet-induced obese mice
by: Yanwen Wang, et al.
Published: (2015-10-01) -
Secoisolariciresinol Diglucoside of Flaxseed and Its Metabolites: Biosynthesis and Potential for Nutraceuticals
by: Parfait Kezimana, et al.
Published: (2018-12-01) -
Flaxseed secoisolariciresinol diglucoside (SDG) during lactation improves bone metabolism in offspring at adulthood
by: Mariana Sarto Figueiredo, et al.
Published: (2017-02-01) -
Phase I and II enzyme induction and inhibition by secoisolariciresinol diglucoside and it's aglycone
by: Boyd, Erin Margaret Rose
Published: (2007)